Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Value Market Research | PRODUCT CODE: 1583823

Cover Image

PUBLISHER: Value Market Research | PRODUCT CODE: 1583823

Global HbA1c Testing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

PUBLISHED:
PAGES: 170 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 3920
PDF & Excel (10-user License)
USD 4730
PDF & Excel (Corporate User License)
USD 7430

Add to Cart

The global demand for HbA1c Testing Market is presumed to reach the market size of nearly USD 6.12 Billion by 2032 from USD 2.77 Billion in 2023 with a CAGR of 9.22% under the study period 2024-2032.

HbA1c testing measures the average blood glucose levels over the past two to three months by assessing the glycated hemoglobin in blood samples. Often used to monitor diabetes management, this test reflects long-term glucose control rather than daily fluctuations, providing a more comprehensive view of a person's blood sugar levels. HbA1c results help healthcare providers adjust treatments and evaluate diabetes risks, with levels above specific thresholds indicating poor glucose control. Routine HbA1c testing is essential for diabetes management, guiding patients in achieving target blood sugar levels, reducing risks of complications, and promoting overall metabolic health.

Market Dynamics

The HbA1c testing market is witnessing growth due to the rising prevalence of diabetes and the need for effective glucose monitoring. HbA1c tests provide valuable insights into long-term blood sugar control, making them essential for diabetes management and monitoring. As diabetes rates increase globally, healthcare providers are emphasizing routine HbA1c testing to prevent complications and improve patient outcomes. Technological advancements in point-of-care testing and at-home testing kits have further propelled the HbA1c testing market, enabling faster and more convenient testing options for patients. Government healthcare programs and initiatives focused on diabetes awareness and prevention have also contributed to the demand for HbA1c testing. Growing health consciousness and preventive healthcare practices continue to drive the HbA1c testing market as individuals prioritize regular health monitoring. However, the lack of awareness in underdeveloped regions and high testing costs may challenge the HbA1c Testing market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of HbA1c Testing. The growth and trends of HbA1c Testing industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the HbA1c Testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Laboratory-Based Testing
  • Point-Of-Care (POC) Testing

By Technology

  • Immunoassays
  • Chromatography
  • Enzymatic Assays
  • Boronate Affinity Chromatography
  • High-Performance Liquid Chromatography
  • Other

By End-use

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Homecare Settings
  • Other
  • Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the HbA1c Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the HbA1c Testing market include Abbott Laboratories, Arkray Inc., Bio-Rad Laboratories Inc., Ceragem Medisys Inc., Danaher Corporation, EKF Diagnostics, F. Hoffmann-La Roche Ltd., Human, Menarini Diagnostics S.R.L., PTS Diagnostics, Randox Laboratories Ltd., Sakae Co. Ltd., Sekisui Medical Co. Ltd., Siemens Healthineers AG, Trinity Biotech Plc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11210079

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. HBA1C TESTING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Technology
    • 3.7.3 Market Attractiveness Analysis By End-use
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL HBA1C TESTING MARKET ANALYSIS BY TYPE

  • 5.1. Overview By Type
  • 5.2. Historical and Forecast Data Analysis By Type
  • 5.3. Laboratory-Based Testing Historic and Forecast Sales By Regions
  • 5.4. Point-Of-Care (POC) Testing Historic and Forecast Sales By Regions

6. GLOBAL HBA1C TESTING MARKET ANALYSIS BY TECHNOLOGY

  • 6.1. Overview By Technology
  • 6.2. Historical and Forecast Data Analysis By Technology
  • 6.3. Immunoassays Historic and Forecast Sales By Regions
  • 6.4. Chromatography Historic and Forecast Sales By Regions
  • 6.5. Enzymatic Assays Historic and Forecast Sales By Regions
  • 6.6. Boronate Affinity Chromatography Historic and Forecast Sales By Regions
  • 6.7. High-Performance Liquid Chromatography Historic and Forecast Sales By Regions
  • 6.8. Other Historic and Forecast Sales By Regions

7. GLOBAL HBA1C TESTING MARKET ANALYSIS BY END-USE

  • 7.1. Overview By End-use
  • 7.2. Historical and Forecast Data Analysis By End-use
  • 7.3. Hospitals & Clinics Historic and Forecast Sales By Regions
  • 7.4. Diagnostic Laboratories Historic and Forecast Sales By Regions
  • 7.5. Homecare Settings Historic and Forecast Sales By Regions
  • 7.6. Other Historic and Forecast Sales By Regions

8. GLOBAL HBA1C TESTING MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE HBA1C TESTING COMPANIES

  • 9.1. HbA1c Testing Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF HBA1C TESTING INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Abbott Laboratories
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Arkray Inc.
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Bio-Rad Laboratories Inc.
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Ceragem Medisys Inc.
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Danaher Corporation
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. EKF Diagnostics
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. F. Hoffmann-La Roche Ltd.
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Human
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Menarini Diagnostics S.R.L.
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. PTS Diagnostics
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. Randox Laboratories Ltd.
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments
  • 10.14. Sakae Co. Ltd.
    • 10.14.1 Company Overview
    • 10.14.2 Company Revenue
    • 10.14.3 Products
    • 10.14.4 Recent Developments
  • 10.15. Sekisui Medical Co. Ltd.
    • 10.15.1 Company Overview
    • 10.15.2 Company Revenue
    • 10.15.3 Products
    • 10.15.4 Recent Developments
  • 10.16. Siemens Healthineers AG
    • 10.16.1 Company Overview
    • 10.16.2 Company Revenue
    • 10.16.3 Products
    • 10.16.4 Recent Developments
  • 10.17. Trinity Biotech Plc
    • 10.17.1 Company Overview
    • 10.17.2 Company Revenue
    • 10.17.3 Products
    • 10.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

Product Code: VMR11210079

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Type (USD MN)
  • Laboratory-Based Testing Market Sales By Geography (USD MN)
  • Point-Of-Care (POC) Testing Market Sales By Geography (USD MN)
  • Analysis By Technology (USD MN)
  • Immunoassays Market Sales By Geography (USD MN)
  • Chromatography Market Sales By Geography (USD MN)
  • Enzymatic Assays Market Sales By Geography (USD MN)
  • Boronate Affinity Chromatography Market Sales By Geography (USD MN)
  • High-Performance Liquid Chromatography Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Analysis By End-use (USD MN)
  • Hospitals & Clinics Market Sales By Geography (USD MN)
  • Diagnostic Laboratories Market Sales By Geography (USD MN)
  • Homecare Settings Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Global HbA1c Testing Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of HbA1c Testing Report
  • Market Research Process
  • Market Research Methodology
  • Global HbA1c Testing Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Type
  • Market Attractiveness Analysis By Technology
  • Market Attractiveness Analysis By End-use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Type (USD MN)
  • Laboratory-Based Testing Market Sales By Geography (USD MN)
  • Point-Of-Care (POC) Testing Market Sales By Geography (USD MN)
  • Global Market Analysis By Technology (USD MN)
  • Immunoassays Market Sales By Geography (USD MN)
  • Chromatography Market Sales By Geography (USD MN)
  • Enzymatic Assays Market Sales By Geography (USD MN)
  • Boronate Affinity Chromatography Market Sales By Geography (USD MN)
  • High-Performance Liquid Chromatography Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Global Market Analysis By End-use (USD MN)
  • Hospitals & Clinics Market Sales By Geography (USD MN)
  • Diagnostic Laboratories Market Sales By Geography (USD MN)
  • Homecare Settings Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!